Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation

Bone Marrow Transplantation

Volumn 18, Issue 3, 1996, Pages 569-572

  Devine, S M ^a   Newman, N J ^a   Siegel, J L ^a   Joseph, G J ^a   Geis, T C ^a   Schneider, J A ^a   Geller, R B ^a   Wingard, J R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BMT; Cerebral blindness; FK506; GVHD

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DIAZEPAM; METHOTREXATE; METHYLPREDNISOLONE; PHENYTOIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CEREBRAL BLINDNESS; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DRUG USE; FEMALE; GAIT DISORDER; GRAFT VERSUS HOST REACTION; HEADACHE; HEMIANOPIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; MALE; MUCOSA INFLAMMATION; MYELODYSPLASTIC SYNDROME; NAUSEA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RADIOLOGY; TONIC CLONIC SEIZURE; VERTIGO; VOMITING;

ADULT; BLINDNESS; BONE MARROW TRANSPLANTATION; BRAIN; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; TACROLIMUS;

EID: 0029840123     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Fung JJ, Todo S, Tzakis A et al. Current status of FK506 in liver transplantation. Transplant Proc 1991; 23: 1902-1905.
2. The US Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. New Engl J Med 1994; 331: 1110-1115.
3. Fay J, Weisdorf D, Wingard J et al. FK506 monotherapy for prevention of graft versus host disease after histocompatible sibling marrow transplantation. Blood 1996; 87: 3514-3519.
4. Eidelman BH, Abu-Elmagd K, Wilson J et al. Neurologic complications of FK506. Transplant Proc 1991; 23: 3175-3178.
5. DeGroen PC, Aksamit AJ, Rakela J et al. Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. New Engl J Med 1987; 317: 861-866.
6. Wilson SE, De Groen PC, Aksanit AJ et al. Cyclosporin-A induced reversible cortical blindness. J Clin Neuroophthalmol 1988; 8: 215-220.
7. Truwit CL, Denaro CP, Lake JR, Demarco T. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR 1991; 12: 651-659.
8. Shutter LA, Green JP, Newman NK et al. Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation. Neurology 1993; 43: 2417-2418.
9. Ishioka M, Ohno S, Nakamura S et al. FK 506 treatment of noninfectious uveitis. Am J Ophthalmol 1994; 118: 723-729.
10. Wisdicks EFM, Wiesner RH, Dahlke LS, Krom RAF. FK506 induced neurotoxicity in liver transplantation. Ann Neurol 1994; 35: 498-501.